Resource Center

Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
background image - desktop
Translational Pharmaceutics

Case Study: Ensysce Biosciences

Learn more

191 - 200 of 202 results

Scientific Poster, Bioanalysis
Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Download Now
Scientific Poster, Bioanalysis
EBF 2021: Novel Copper Protein Speciation Method for Calculating Serum Non Ceruloplasmin Copper: A Comparative Analysis
Download Now
Scientific Poster, Bioanalysis
EBF 2021: Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Download Now
Scientific Poster, Modified Release
AAPS 2021: Pharmaceutical and clinical performance comparisons of modified release multiparticulates and matrix tablet formulations
Download Now
Scientific Poster, Solubility Enhancement, Modified Release, Modelling & Simulation
AAPS 2021: Development and Application of a PBPK Model Using Theoretical Particle Size Distribution to Describe in vivo D issolution to Predict the Impact of Formulation Changes on Oral Bioavailability of GB001
Download Now
Scientific Poster, Pediatrics, Drug Product Optimization
EuPFI 2021: Taste Assessment Study of Belumosudil to Inform an Integrated Pediatric Formulation Development Program
Download Now
Scientific Poster, Pediatrics, Formulation Development
EuPFI 2021: Development of a Novel Pediatric Belumosudil Oral Suspension
Download Now
Scientific Poster, Modified Release
CRS 2021 Poster: Using formulation design spaces and clinical data to optimize development of modified release (MR) dosage forms
Download Now
Scientific Poster, Clinical Pharmacology, First-in-Human
ASCPT 2021 Poster: A First in Human (FIH) Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses, and Alternative Formulations of R941552 (R552): A selective Receptor Interacting Protein 1 (RIP1) Kinase Inhibitor
Download Now
Scientific Poster, Clinical Pharmacology
HBI-3000: A Novel Drug for Conversion of Atrial Fibrillation - Phase 1 Study Results
Download Now